In melanoma cells, it was suggested that atorvastatin could block cell invasion by altering endogenous Rho signaling [77], while in glioma cells, atorvastatin reduces cell invasiveness by suppressing the microglial membrane type 1 metalloproteinase (MT1-MMP) expression [82]. The gene discussed is RHO; the disease is central nervous system cancer.